![Darryl Maher](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 10 073 $ al 31/05/2026
Darryl Maher currently works at Cynata Therapeutics Ltd., as Independent Non-Executive Director from 2020.
Dr. Maher also formerly worked at CSL Behring (Australia) Pty Ltd., as Vice President-Research & Development and Australian Pharmaceutical Physicians Association, as President.
Dr. Maher received his doctorate degree from the University of Melbourne.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 50.000 ( 0,02 % ) | 10 073 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Director/Miembro de la Junta | 16/06/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
Australian Pharmaceutical Physicians Association | Presidente | - |
CSL Behring (Australia) Pty Ltd.
 CSL Behring (Australia) Pty Ltd. BiotechnologyHealth Technology Engages in R&D and production of biotechnology products | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
 Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
CSL Behring (Australia) Pty Ltd.
CSL Behring (Australia) Pty Ltd. BiotechnologyHealth Technology Engages in R&D and production of biotechnology products | Health Technology |
Australian Pharmaceutical Physicians Association |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
